A pathogenetic link between non-alcoholic fatty liver disease and celiac disease

被引:29
作者
Abenavoli, Ludovico [1 ]
Milic, Natasa [2 ]
De Lorenzo, Antonino [3 ]
Luzza, Francesco [1 ]
机构
[1] Univ Magna Gracia, Dept Hlth Sci, I-88100 Catanzaro, Italy
[2] Univ Novi Sad, Dept Pharm, Novi Sad 21000, Serbia
[3] Univ Roma Tor Vergata, Div Human Nutr, Dept Neurosci, I-00133 Rome, Italy
关键词
Non-alcoholic fatty liver disease; Celiac disease; Intestinal permeability; Microbiota; INCREASED INTESTINAL PERMEABILITY; CONFOUNDING FACTOR; MEDICAL PROGRESS; STEATOHEPATITIS; ENDOTOXEMIA; PREVALENCE; DIAGNOSIS; INJURY;
D O I
10.1007/s12020-012-9731-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) has recently been recognized as the leading cause of the abnormalities in the liver function tests in the Western countries. Celiac disease (CD) is a permanent immunological intolerance to gluten proteins in genetically predisposed individuals. CD has been reported in 4-13 % of the cases with steatohepatitis, although the pathogenesis of the liver steatosis in CD patients is unclear. Based on the literature data, it can be concluded that the inclusion of serological markers of CD should be a part of the general workup in the patients with steatosis when other causes of the liver disease are excluded and in the patients with NAFLD when metabolic risk factors are not evident.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 25 条
[1]   CELIAC DISEASE, PRIMARY BILIARY CIRRHOSIS AND HELICOBACTER PYLORI INFECTION: ONE LINK FOR THREE DISEASES [J].
Abenavoli, L. ;
Arena, V. ;
Giancotti, F. ;
Vecchio, F. M. ;
Abenavoli, S. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (04) :1261-1265
[2]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[3]   Searching for coeliac disease in patients with non-alcoholic fatty liver disease [J].
Bardella, MT ;
Valenti, L ;
Pagliari, C ;
Peracchi, M ;
Farè, M ;
Fracanzani, AL ;
Fargion, S .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (05) :333-336
[4]   Epidemiology of Non-Alcoholic Fatty Liver Disease [J].
Bellentani, Stefano ;
Scaglioni, Federica ;
Marino, Mariano ;
Bedogni, Giorgio .
DIGESTIVE DISEASES, 2010, 28 (01) :155-161
[5]   Increased intestinal permeability in obese mice:: new evidence in the pathogenesis of nonalcoholic steatohepatitis [J].
Brun, Paola ;
Castagliuolo, Ignazio ;
Di Leo, Vincenza ;
Buda, Andrea ;
Pinzani, Massimo ;
Palu, Giorgio ;
Martines, Diego .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (02) :G518-G525
[6]   Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease [J].
Day, C. P. .
LIVER INTERNATIONAL, 2006, 26 (09) :1021-1028
[7]   Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[8]   Intestinal permeation and gastrointestinal disease [J].
DeMeo, MT ;
Mutlu, EA ;
Keshavarzian, A ;
Tobin, MC .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (04) :385-396
[9]   Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis [J].
Farhadi, Ashkan ;
Gundlapalli, Sushama ;
Shaikh, Maliha ;
Frantzides, Constantine ;
Harrell, Laura ;
Kwasny, Mary M. ;
Keshavarzian, Ali .
LIVER INTERNATIONAL, 2008, 28 (07) :1026-1033
[10]  
Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772